KRAS G12C inhibitor 59
KRAS G12C Inhibitor 59 is a potent and selective small molecule designed for cancer research. It covalently targets the KRAS G12C mutant protein, inhibiting its oncogenic signaling. This compound is a valuable tool for in vitro and in vivo studies exploring targeted therapies in cancers such as non-small cell lung cancer and colorectal adenocarcinoma.
Product Specifications
CAS Number
2914919-88-1
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
FC (F) (F) C (C (C) =CC (N) =C1F) =C1[C@@H]2CC3=NC (OC[C@@]45N (CCC5) C[C@@H] (C4) F) =NC (N6C[C@@H] (N (CC6) C (C (F) =C) =O) CC#N) =C3CO2.O.O
Molecular Formula
C32H39F6N7O5
Molecular Weight
715.69
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040043-100 1x 100 µL
P21 / WAF1 (WA-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040270-100 1x 100 µL
Fibronectin (HFN7.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740031-500 1x 500 µL
Mucin 5AC (MUC5AC) (45M1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942298-500 1x 500 µL
Cytokeratin 8/18 (rKRT8.18/1346), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details